The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Quinlan Kevin W since year 2005.
The trader's CIK number is 1209114.
At the time of this reporting, Quinlan Kevin W is the Chief Financial Offi of Anika Therapeutics Inc .
(stock ticker symbol ANIK).
See this page for all insider trading activities at Anika Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2013-03-27||ANIK||Anika Therapeutics Inc||Sale||18,374||11.24||206,523|
|2013-03-22||ANIK||Anika Therapeutics Inc||Sale||31,626||11.24||355,476|
|2013-03-21||ANIK||Anika Therapeutics Inc||Sale||25,000||11.24||281,000|
|2013-02-27||ANIK||Anika Therapeutics Inc||Option Ex||11,368||6.99||79,462|
|2010-08-23||ANIK||Anika Therapeutics Inc||Buy||4,000||5.00||20,000|
|2008-11-07||ANIK||Anika Therapeutics Inc||Buy||1,000||5.20||5,200|
|2008-11-06||ANIK||Anika Therapeutics Inc||Buy||1,000||5.34||5,340|
|2008-03-19||ANIK||Anika Therapeutics Inc||Buy||2,000||8.27||16,534|
|2008-03-10||ANIK||Anika Therapeutics Inc||Buy||1,000||9.88||9,875|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Quinlan Kevin W (Chief Financial Offi of Anika Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.